CHARACTERIZATION OF HUMAN PROSTATE-CANCER, BENIGN PROSTATIC HYPERPLASIA AND NORMAL PROSTATE BY IN-VITRO H-1 AND P-31 MAGNETIC-RESONANCE SPECTROSCOPY

被引：77

作者：

CORNEL, EB

SMITS, GAHJ

OOSTERHOF, GON

KARTHAUS, HFM

DEBRUYNE, FMJ

SCHALKEN, JA

HEERSCHAP, A

机构：

[1] UNIV HOSP NIJMEGEN, DEPT UROL, GEERT GROOTEPLE, N ZUID 16, POB 9101, 6500 HB NIJMEGEN, NETHERLANDS

[2] UNIV HOSP NIJMEGEN, DEPT RADIOL, NIJMEGEN, NETHERLANDS

[3] CANISIUS WILHELMINA HOSP, DEPT UROL, NIJMEGEN, NETHERLANDS

来源：

JOURNAL OF UROLOGY | 1993年 / 150卷 / 06期

关键词：

METABOLISM; NUCLEAR MAGNETIC RESONANCE; PROSTATIC NEOPLASMS; PROSTATE; PROSTATIC HYPERTROPHY;

D O I：

10.1016/S0022-5347(17)35957-8

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

In vitro H-1 and P-31 magnetic resonance spectra were acquired from perchloric acid extracts of human prostate tissue obtained by transurethral resection. This included tissue of patients with benign prostatic hyperplasia and prostatic adenocarcinoma; one tissue sample was obtained from a patient without any sign of BPH or malignancy. Major resonances in the magnetic resonance spectra were assigned to prostate compounds and were quantified. The citrate/lactate, citrate/total choline, phosphocholine/total creatinine, choline/total creatine, alanine/total creatine, phosphoethanolamine/total phosphate, phosphocholine/total phosphate and glycerophosphoethanolamine/total phosphate ratios were statistically different for the prostate cancer samples as compared with the BPH specimens. These observations may contribute to the understanding of in vivo magnetic resonance spectra of the prostate and indicate that magnetic resonance spectroscopy can aid in the diagnosis of prostate malignancy.

引用

页码：2019 / 2024

页数：6

共 32 条

[21] Glonek T., Kopp S.J., Ex vivo P-31nmr of lens, cornea, heart, and brain, Magn. Reson. Imaging, 3, (1985)
[22] Brown T.W., Graham R.A., Szwergold B.S., Thoma W.J., Meyer R.A., Phosphorylated metabolites in tumors, tissues, and cell lines, Ann. N. Y. Acad. of Sci., 508, (1987)
[23] Marberger H., Marberger E., Mann T., Lutwak-Mann C., Citric acid in human prostatic secretion and metastasizing cancer of the prostate, Br. Med. J., 1, (1962)
[24] Cooper J.F., Farid I., The role of citric acid in the physiology of the prostate: III. Lactate/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy, J. Urol., 92, (1964)
[25] Costello L.C., Franklin R.B., Prostate epithelial cells utilize glucose and aspartate as carbon sources for net citrate production, Prostate, 15, (1989)
[26] Costello L.C., Littleton G.K., Franklin R.B., Regulation of citrate-related metabolism in normal and neoplastic prostate, pp. 303-314, (1978)
[27] Daly P.F., Lyon R.C., Faustino P.J., Cohen J.S., Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy, J. Biol. Chem., 31, (1987)
[28] Cohen J.S., Phospholipid and energy metabolism of cancer cells monitored by 31P magnetic resonance spectroscopy: possible clinical significance, Mayo Clin. Proc., 63, (1988)
[29] Ruiz-Cabello J., Cohen J.S., Phospholipid metabolites as indicators of cancer cell function, NMR Biomed., 5, (1992)
[30] Merchant T.E., Gierke L.W., Meneses P., Glonek T., 31P magnetic resonance spectroscopic profiles of neoplastic human breast tissues, Cancer Res., 48, (1988)

← 1 2 3 4 →